Salud financiera de hoja de balance de J. B. Chemicals & Pharmaceuticals
Salud financiera controles de criterios 6/6
J. B. Chemicals & Pharmaceuticals tiene un patrimonio de accionistas total de ₹32.1B y una deuda total de ₹816.4M, lo que sitúa su ratio deuda-patrimonio en 2.5%. Sus activos y pasivos totales son ₹40.3B y ₹8.2B respectivamente. El BAIT de J. B. Chemicals & Pharmaceuticals es de ₹8.1B, por lo que su ratio de cobertura de intereses es de 33.1. Tiene efectivo e inversiones a corto plazo que ascienden a ₹4.2B.
Información clave
2.5%
Ratio deuda-patrimonio
₹816.40m
Deuda
| Ratio de cobertura de intereses | 33.1x |
| Efectivo | ₹4.17b |
| Patrimonio | ₹32.12b |
| Total pasivo | ₹8.17b |
| Activos totales | ₹40.29b |
Actualizaciones recientes sobre salud financiera
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29Recent updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 09J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹19.1B) de JBCHEPHARM superan a sus pasivos a corto plazo (₹6.2B).
Pasivo a largo plazo: Los activos a corto plazo de JBCHEPHARM (₹19.1B) superan a sus pasivos a largo plazo (₹2.0B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: JBCHEPHARM tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de JBCHEPHARM ha pasado de 3% a 2.5% en los últimos 5 años.
Cobertura de la deuda: La deuda de JBCHEPHARM está bien cubierta por el flujo de caja operativo (912.6%).
Cobertura de intereses: Los pagos de intereses de la deuda de JBCHEPHARM están bien cubiertos por el BAIT (33.1x cobertura).